Office of Professional Education

A free CME/CNE/MOC evening symposium

An educational collaboration with Mount Sinai – National Jewish Health Respiratory Institute and National Jewish Health

Register Now


Dates & Locations:

San Francisco, CA  – Monday, November 5, 2018 
 JW Marriott San Francisco Union Square (Dr. Michael Wechsler)
 515 Mason Street, San Francisco, CA 94102

Houston, TX – Wednesday, November 14, 2018 
 Le Méridien Houston Downtown (Dr. Michael Wechsler)
 1121 Walker St., Houston, TX 77002
Valet parking is complimentary. Please bring your ticket to the registration desk to be validated.


The symposium is from 6:30 p.m.- 8:30 p.m. 
Registration/Dinner starts at 6:00 p.m.

Dinner and the syllabus are provided at no charge.


Target Audience:

This activity is designed to meet the educational needs of allergists, pulmonologists, primary care physicians, pediatricians, physician assistants, advanced practice nurses and registered nurses who treat patients with asthma.


Learning Objectives:

Upon completion of this activity, the participant will be better able to:

  1. Describe key concepts in the pathophysiology of severe asthma and the features that are targets for biologic therapies.

  2. Distinguish severe asthma from difficult-to-treat asthma with improved diagnosis and assessment strategies, including proper inhaler technique.

  3. Review emerging evidence related to targeted therapies and potential biomarkers to select personalized treatment in severe asthma according to asthma subtype.


Program Series Faculty:

Michael E. Wechsler, MD, MMSc (Program Co-Chair)
Professor of Medicine
Director of the Cohen Family Asthma Institute
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health, Denver, CO 

Linda Rogers, MD (Program Co-Chair)
Associate Professor of Medicine
Pulmonary, Critical Care and Sleep Medicine
Director, Clinical Asthma Program
Icahn School of Medicine at Mount Sinai
Mount Sinai – National Jewish Health Respiratory Institute 



For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email


Registration Information:

* Indicates required field
Choose Date to Attend: *




(NPI numbers are listed


please provide State License Number and State)


Please Note:

You are registered for a meeting ONLY when a red box stating confirmation of registration appears on your screen when you click submit, and then an email confirmation is received in your inbox. If you have questions, please call 800.844.2305.


Accreditation and Designation Statements:

Physicians:  National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this live educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, A Severe Asthma Roadmap for Improved Diagnosis and Personalized Treatment – A Guided Workflow has met the requirements as an MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Allergy and Immunology
Family Medicine

Registered Nurses:  Provider approved by the California Board of Registered Nursing, Provider Number 12724, for 2.4 contact hours.



This educational activity is supported by independent educational grants from AstraZeneca Pharmaceuticals LP and Novartis Pharmaceuticals Corporation.